The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPHRM.L Regulatory News (PHRM)

  • There is currently no data for PHRM

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Global Operations Update

27 Jun 2014 07:30

RNS Number : 6981K
Phorm Corporation Limited
27 June 2014
 

27 June 2014

 

Phorm Corporation Limited

("Phorm" or the "Company")

 

Global Operations Update

Revenue and KPIs Growing Strongly

Phorm (AIM: PHRM), a leading internet personalisation technology company, announces an unaudited operational and financial update demonstrating that the group's revenues and key performance indicators (KPIs) are continuing to grow strongly.

Highlights:

· Peak daily unique user numbers have increased 44 times from approximately 838,000 in H1 2013 to in excess of 30 million in H1 2014

· Advertising requests have increased 35 times from approximately 1.6 billion in H1 2013 to approximately 60 billion in H1 2014

· Advertising impressions served have increased 35 times from approximately 63 million in H1 2013 to over 2.3 billion in H1 2014

· Revenue has grown by more than 14 times year-on-year, H1 2013 versus H1 2014*

· Monthly revenue from January to May 2014 has grown by over 300%

· Revenue growth is expected to accelerate significantly in H2 2014, following the recent growth in user numbers and advertising requests

 

On 24 October 2013, Phorm announced that it had experienced strong growth in its KPIs and on 27 January 2014 further announced that it had launched commercial operations in China. The Company is pleased to announce that the group's strong growth trend in revenue and other KPIs is continuing.

 

Key Performance Indicator

H1 2013

H2 2013

H1 2014*

Yr-on-Yr

Peak Daily Unique Users (m)

0.8

14.1

37.8

44x

Total Advertising Requests (bn)

1.6

22.3

59.9

35x

Total Advertisements Served (m)

63.0

777.8

2,328.6

35x

Total Revenues (US$'000s)

28.5

251.2

>400.0

14x

Note:

* Total revenues for H1 2014 are for the five-month period to 31 May 2014 i.e. excluding June 2014. Users, Advertising Requests and Advertisements Served are for the period from 1 January 2014 to 19 June 2014

 

As outlined in the Company's 2013 Annual Report published today, there are four main drivers of Phorm's business, being: users, publishers, advertisers and advertisement performance. All of these key elements need to be developed and progressed in each target market before significant revenues can be generated.

 

On 27 March 2014, the Company announced that it had reached a total of over 30 million daily unique users globally. The peak daily unique user number in H1 2013 has increased approximately 44 times year-on-year in H1 2014. The growth in user numbers has been driven primarily by the development of new markets and is currently expected to translate into higher revenues over the coming months, as both inventory and advertising campaigns increase.

 

Inventory refers to the number of advertising slots on web pages that are made available to Phorm's system. Inventory is presented as an advertising request from the publisher site as a web page loads on a user's browser. The number of advertising requests received demonstrates the strength of Phorm's publisher partnerships. The number of partnerships has increased and advertising requests have grown significantly, increasing 35 times year-on-year from approximately 1.6 billion in H1 2013 to approximately 60 billion in H1 2014.

 

The main challenge that the Company has faced in recent years has been the relatively small number of users, which has had a major impact on the group's ability to monetise the advertising requests sent from publishers. Of the approximate 1.6 billion advertising requests received in H1 2013, only 129 million, or 8 per cent., related to users who had consented to Phorm's system. In H1 2014, the total number of requests had risen to approximately 60 billion and over 27 billion of these, or 45 per cent., were from Phorm users.

 

The growth in the number of advertising requests attributable to Phorm users has greatly improved the Company's ability to deliver larger advertising campaigns more rapidly, thereby enhancing the rate of revenue generation.

 

The total number of advertising impressions actually served has increased approximately 35 times from 63 million in H1 2013 to over 2.3 billion in H1 2014. Phorm currently expects this growth to strengthen over the remainder of 2014 with the gathering momentum and further commercialisation of its operations in China.

 

On 30 September 2013, Phorm announced that its total revenue for the six months ended 30 June 2013 was US$28,545. The Company is pleased to announce that its unaudited total revenue for the period from 1 January 2014 to the end of May 2014 is over US$400,000 representing an increase of over 14 times on H1 2013. Based on the lead KPIs of user numbers, advertising requests and advertising impressions, the Company currently expects this growth to continue to strengthen through the remainder of 2014.

 

The Company is focused on accelerating the rate of revenue growth while maintaining the high standards of advertising performance achieved to date and will provide further updates in due course.

 

-Ends-

 

For further information please contact:

 

Phorm Corporation Limited

Andy Croxson (analysts and investors) +44 (0) 203 397 6001

 

UK Investors

Mirabaud Securities LLP +44 20 7321 2508 (Broker)

Jason Woollard

Peter Krens

 

Strand Hanson Limited +44 20 7409 3494 (Nominated Adviser)

James Harris

Matthew Chandler

James Dance

 

US Investors

Lippert/Heilshorn and Associates +1 212 838 3777 (Investor Relations)

John Heilshorn

 

 

 

 

About Phorm

 

Phorm is a global personalisation technology company that makes content and advertising more relevant to the consumer. Phorm's innovative platform preserves user privacy and delivers a more interesting online experience.

 

Phorm's industry leading technology enables its Internet Service Provider ("ISP") partners to offer a new type of online advertising platform and a free consumer internet content feature, ensuring more relevant advertisements and personalised content for opted-in users.

 

Phorm's advertising platform revolutionises current standards of online privacy, fully protecting the identity of consumers. Phorm's solution is completely opt-in. Only those users consenting to the service are profiled and only ever on an anonymous basis.

 

Phorm's partners include leading ISPs, Publishers, Advertising Networks and Advertisers.

 

Phorm, under a predecessor holding company, was admitted to the AIM market of the London Stock Exchange in 2004.

 

For more information, please visit: www.phorm.com

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCUNVURSSANUUR
Date   Source Headline
5th Jan 20107:00 amRNSTransfer of shares
17th Dec 200911:51 amRNSPurchase of Shares and Total Voting Rights
4th Nov 20092:18 pmRNSNotification of major interest in shares
2nd Nov 200912:42 pmRNSResult of AGM
6th Oct 20092:07 pmRNSNotice of AGM
2nd Oct 20097:00 amRNSNotification of major interest in shares
21st Sep 20097:00 amRNSInterim results
14th Sep 20098:57 amRNSNotification of Results
5th Aug 20097:00 amRNSTransfer of Shares
8th Jul 20098:27 amRNSOperational Update
6th Jul 20099:22 amRNSStatement on UK operations
30th Jun 20097:13 amRNSAnnual Accounts
19th Jun 200911:06 amRNSTotal Voting Rights
18th Jun 20097:00 amRNSFinal Results
10th Jun 20097:00 amRNSPlacing to raise ?15 million
3rd Jun 200911:00 amRNSPhorm announces Webwise Discover
21st May 20097:00 amRNSKorean Market Trial
27th Apr 200910:31 amRNSStatement re Apology from "New Media Age" Magazine
14th Apr 20096:23 pmRNSPhorm Statement re EU Commission
9th Apr 20093:57 pmRNSAIM Block Admission
30th Mar 20097:00 amRNSKorean Market Trial
26th Mar 20097:03 amRNSGrant of Options
19th Mar 20091:31 pmRNSGrant of Options
18th Mar 20097:00 amRNSChange of Broker
13th Mar 20095:03 pmRNSShare Issue - Replacement
13th Mar 20092:46 pmRNSShare Issue
11th Mar 20099:49 amRNSAnnouncement of Appointments
4th Mar 20093:18 pmRNSCity Events Wire
17th Dec 20085:52 pmRNSManagement Appointments
15th Dec 20087:00 amRNSBT Trial Update
1st Dec 20087:00 amRNSPhorm Announces Board Changes
5th Nov 20087:46 amRNSDisclosure of Share Sale
22nd Oct 20085:14 pmRNSGrant of options
14th Oct 200810:15 amRNSCancellation of admission of shares
30th Sep 20087:00 amRNSInterim Results
29th Sep 20087:00 amRNSCommencement of BT Trial
22nd Sep 200811:15 amRNSResponse to Statement by BERR
4th Sep 20087:00 amRNSPhorm Update
18th Aug 20087:00 amRNSAppointment of Independent Bo
24th Jun 20087:00 amRNSTransfer of Shares
14th May 20084:45 pmRNSExercise of Options
14th May 200812:55 pmRNSAnnual Report and Accounts
10th Apr 20087:01 amRNSFinal Results
4th Apr 20084:23 pmRNSNotification of Holding
4th Apr 20084:16 pmRNSNotification Of Shareholding
4th Apr 200812:11 pmRNSNotification Of Shareholding
19th Mar 20087:01 amRNSIssue of Equity
13th Mar 200811:32 amRNSResult of Stockholder Meeting
11th Mar 20087:02 amRNSRe Share Price Movement
28th Feb 20085:50 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.